LNCARSR

Across TCGA pan-cancer cohorts, LNCARSR RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated LNCARSR data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher LNCARSR RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated LNCARSR expression acts as an unfavorable survival marker, although some lineages such as BRCA and SKCM show a favorable association.

BRCA, LGG, and SKCM are the cancer types where LNCARSR RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	DFS	Median	II,III,IV	0.584	0.456	.001	65	view →
LGG	DFS	Median	All	0.637	0.823	<.001	51	view →
SKCM	DFS	Quartile	II,III,IV	0.714	0.542	<.001	45	view →
ACC	DFS	Tertile	IV	0.010	0.383	<.001	27	view →
UCS	OS	Tertile	IV	0.308	0.708	.010	24	view →
DLBC	OS	Quartile	All	0.715	1.000	.004	24	view →
THCA	OS	Tertile	III,IV	0.875	1.000	<.001	16	view →
CHOL	DFS	Tertile	II,III,IV	1.000	0.147	.041	15	view →
LUAD	DFS	Quartile	All	0.879	0.754	.002	14	view →
KICH	OS	Tertile	II,III,IV	0.155	0.880	<.001	12	view →
PAAD	DFS	Tertile	II,III,IV	0.556	0.363	.011	10	view →
THYM	DFS	Quartile	II,III,IV	1.000	0.652	.013	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

LNCARSR–BRCA (DFS)

Open the BRCA breakdown →